Drugs of Abuse Testing Market is anticipated to reach at USD 3,720 Million by 2025 at a 5.4% CAGR during forecast period.

Drug of abuse testing is used for screening or identification of illicit drugs consumption in a person’s sample such as urine, hair, breath, blood, etc. Drug of abuse testing is extremely complex and proper interpretation requires a specialized device, kits, and expertise. Drug of abuse testing is used increasingly as a deterrent to illicit drug use and as an objective means to document drug abuse among patients, job applicants, employees, athletes, and students. Several illicit drugs such as opioids, cocaine, LSD, amphetamines, alcohol are commonly used as the drug of abuse. According to the CDC Wonder database, in 2017, in the United States, more than 72,000 deaths were from a drug overdose which included illicit drugs and prescription opioids. Drug of abuse testing is routinely performed in the healthcare facilities such as diagnostic lab, hospitals, and mobile clinics.

To have an edge over the competition by knowing the market dynamics and current trends of “Drugs of Abuse Testing Market”, request for Sample Report here

Factors such as growing drug abuse population, increasing demand for a drug of abuse testing from the public and the companies and rising drug-related mortality rates are few of the factors that are driving the growth of the drug of abuse testing market during the forecast period. In addition, rising government programs to overcome or control the drug of abuse and rise in government funding also act as a driver for the growth of drug of abuse market. For instance, the US government has recently funded more than 60 inpatient and outpatient drug treatment centers across the country. In addition, stringent laws, growing adoption of drug testing at the workplace, and an increasing number of toxicological laboratories are some of the factors that are anticipated to boost the market. However, legalization of illicit drugs, social issues associated with the drug of abuse testing, inability to detect low-dose designer drugs, and lack of a global standard definition of a problem drug user are some of the factors which are hindering the growth of the drugs of abuse testing market.

Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report

Various notable players operating in the market, include F. Hoffmann La-Roche Ltd, Siemens Healthineers (Siemens AG), Thermo Fisher Scientific, Inc., Quest Diagnostics, Alere, Inc., Shimadzu Corporation, Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Randox Testing Services, Biomedical Diagnostics, BioMerieux, Bio-Rad, among others.

In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here

The global drugs of abuse testing market is segmented on the basis of product type, drug type, technique type, end user and key geographies. Based on product type, the market comprises instruments and consumables. The research report “global drugs of abuse testing market” provides in-depth analysis of global drugs of abuse testing market based on product type, drug type, technique type, end user and major geographies for the forecast period from 2018 to 2025. The report also highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for the global drugs of abuse testing market. In addition, the report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For detailed scope of the “Drugs of Abuse Testing Market” report request a Sample Copy of the report

Key questions answered in this research report:
1. At what pace is drugs of abuse testing market growing? What will be the growth trend in the future?
2. What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3. What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the drugs of abuse testing market?
4. What are the various application areas and how they are poised to grow?

Market Segmentation

By Product Type
• Instruments
o Analyzers
■ Immunoassays Analyzers
■ Chromatographic Devices
■ Breath Analyzers
o Rapid Testing Devices
■ Urine Testing Devices
■ Oral Fluid Testing Device
• Consumables
o Rapid test kits
o Assay kits & reagents
o Others

By Drug Type
• Psychostimulants
• Narcotic
• Hallucinogens
• Sedatives
• Others

By Technique Type
• Immunoassay
• Chromatography
• Rapid Testing

By End User
• Hospitals
• Diagnostic Laboratories
• Forensic Laboratories
• Government and private departments
• Others

By Geography
• North America
As a part of the customization
o By Product Type
o By Drug Type
o By Technique Type
o By End User
o US
o Canada
o Mexico

• Europe
As a part of the customization
o By Product Type
o By Drug Type
o By Technique Type
o By End User
o UK
o Germany
o Spain
o Rest of Europe

• Asia-Pacific
As a part of the customization
o By Product Type
o By Drug Type
o By Technique Type
o By End User
o China
o Australia
o India
o Rest of APAC

• ROW
As a part of the customization
o By Product Type
o By Drug Type
o By Technique Type
o By End User
o Brazil
o South Africa
o GCC countries
o Rest of world (remaining countries of the LAMEA region)

Leading market players
• F. Hoffmann La-Roche Ltd
• Siemens Healthineers (Siemens AG)
• Thermo Fisher Scientific, Inc.
• Quest Diagnostics
• Alere, Inc.
• Shimadzu Corporation
• Drägerwerk AG & Co. KGaA
• Laboratory Corporation of America Holdings

*Other prominent players in the market which can be profiled as a part of customization:
• United States Drug Testing Laboratories, Inc
• Express Diagnostics International Inc.
• LGC Limited
• Randox Testing Services
• Biomedical Diagnostics
• BioMerieux
• Bio-Rad